Wendy Stock, MD

Wendy Stock, is a prominent hematologist-oncologist specializing in acute and chronic leukemias, particularly adolescent and young adult (AYA) acute lymphoblastic leukemia (ALL). As the Anjuli Seth Nayak Professor of Medicine at the University of Chicago, she is recognized for pioneering biologically risk-adapted clinical trials.

Articles by Wendy Stock, MD

FDA Approves Orca-T After Phase 3 Trial Improves Chronic GVHD-Free Survival

ByWendy Stock, MD

July 14th 2026

Wendy Stock, MD, on the recent FDA approval of Orca-T, a precision-engineered cell therapy for allogeneic transplant in adults with hematological malignancies

Wendy Stock, MD

Articles by Wendy Stock, MD

FDA Approves Orca-T After Phase 3 Trial Improves Chronic GVHD-Free Survival

Latest Updated Articles

Trending on HCPLive

Chronic Hypoparathyroidism Today: Unmet Needs, Conventional Therapy Limits, and the Shift to PTH Replacement

SIGNAL-AA: Bempikibart Effective for Alopecia Areata at 36 Weeks

AHA, ACC Release First-Ever Cardiovascular-Kidney-Metabolic Syndrome Guidelines

Avapritinib 4-Year PIONEER Data: Sustained QoL Gains in ISM

Palopegteriparatide Mechanism and Phase 3 Outcomes in Chronic Hypoparathyroidism